1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. PREIMPLANTATION GENETIC TESTING MARKET BY TECHNOLOGY
5.1. Introduction
5.2. Next Generation Sequencing
5.3. Polymerase Chain Reaction
5.4. Fluorescent In-Situ Hybridization
5.5. Comparative Genomic Hybridization
5.6. Single Molecule Polymorphism
6. PREIMPLANTATION GENETIC TESTING MARKET BY PROCEDURE TYPE
6.1. Introduction
6.2. Preimplantation Genetic Screening
6.3. Preimplantation Genetic Diagnosis
7. PREIMPLANTATION GENETIC TESTING MARKET BY APPLICATION
7.1. Introduction
7.2. Aneuploidy
7.3. Single Gene Disorders
7.4. X-linked Disorders
7.5. Others
8. PREIMPLANTATION GENETIC TESTING MARKET BY END-USER
8.1. Introduction
8.2. Maternity Clinics
8.3. Hospitals
8.4. Others
9. PREIMPLANTATION GENETIC TESTING MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. By Technology
9.2.2. By Procedure Type
9.2.3. By Application
9.2.4. By End-User
9.2.5. By Country
9.2.5.1. United States
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. South America
9.3.1. By Technology
9.3.2. By Procedure Type
9.3.3. By Application
9.3.4. By End-User
9.3.5. By Country
9.3.5.1. Brazil
9.3.5.2. Argentina
9.3.5.3. Others
9.4. Europe
9.4.1. By Technology
9.4.2. By Procedure Type
9.4.3. By Application
9.4.4. By End-User
9.4.5. By Country
9.4.5.1. United Kingdom
9.4.5.2. Germany
9.4.5.3. France
9.4.5.4. Spain
9.4.5.5. Others
9.5. Middle East and Africa
9.5.1. By Technology
9.5.2. By Procedure Type
9.5.3. By Application
9.5.4. By End-User
9.5.5. By Country
9.5.5.1. Saudi Arabia
9.5.5.2. UAE
9.5.5.3. Israel
9.5.5.4. Others
9.6. Asia Pacific
9.6.1. By Technology
9.6.2. By Procedure Type
9.6.3. By Application
9.6.4. By End-User
9.6.5. By Country
9.6.5.1. Japan
9.6.5.2. China
9.6.5.3. India
9.6.5.4. South Korea
9.6.5.5. Indonesia
9.6.5.6. Thailand
9.6.5.7. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Milann Fertility Center
11.2. Pac Genomics
11.3. Thermo Fisher Scientific
11.4. Natera
11.5. Illumina
11.6. Johns Hopkins Medicine
11.7. NYU Langone Health
11.8. Cloudnine Fertility
11.9. MedGenome
11.10. CNY Fertility